PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
51.63%
Revenue growth above 1.5x CX's 13.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
51.63%
Gross profit growth above 1.5x CX's 23.58%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
51.63%
EBIT growth 50-75% of CX's 89.85%. Martin Whitman would suspect suboptimal resource allocation.
51.63%
Operating income growth at 50-75% of CX's 70.77%. Martin Whitman would doubt the firm’s ability to compete efficiently.
114.00%
Positive net income growth while CX is negative. John Neff might see a big relative performance advantage.
100.00%
Positive EPS growth while CX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
100.00%
Positive diluted EPS growth while CX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
7.00%
Share change of 7.00% while CX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
7.00%
Diluted share change of 7.00% while CX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
127.65%
10Y revenue/share CAGR above 1.5x CX's 9.37%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
71.37%
5Y revenue/share CAGR 1.25-1.5x CX's 58.59%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
93.81%
3Y revenue/share CAGR above 1.5x CX's 1.13%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
175.00%
Below 50% of CX's 911.84%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
214.29%
3Y net income/share CAGR above 1.5x CX's 19.86%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.